EPISODE · Dec 1, 2023 · 32 MIN
Apple, Disney, Novo Nordisk, Other Catalysts
from Votes & Verdicts · host Bloomberg
Apple facing an import ban on its watches, a key hearing in Disney v. Florida and a Novo Nordisk claim construction hearing in a $98 billion patent suit to block Mylan’s copy of weight-loss drug Wegovy are key December catalysts to watch. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation analyst Elliott Stein, gathered the team to discuss these and other catalysts. Kenvue and others have a Dec. 7 hearing to bar plaintiffs’ experts in a class action alleging Tylenol caused autism and ADHD in babies when consumed by pregnant women. DuPont and Chemours’ $1.2 billion PFAS pact with public water authorities likely gets final court approval on Dec. 14. The trial is expected to end in the DOJ’s lawsuit challenging the JetBlue-Spirit deal. We also discussed the FDIC’s special assessment of big banks to recoup $16 billion in losses due to regional bank collapses earlier this year, and how stricter federal home loan bank limits may drive up funding costs for US banks.See omnystudio.com/listener for privacy information.
NOW PLAYING
Apple, Disney, Novo Nordisk, Other Catalysts
No transcript for this episode yet
Similar Episodes
Jul 8, 2026 ·29m
Jul 6, 2026 ·84m
Jul 4, 2026 ·23m
Jul 4, 2026 ·89m
Jun 27, 2026 ·20m